- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00760422
Clinical Evaluation of NIR (Non-Invasive Infrared) Thermometer Performance (NIR)
April 19, 2012 updated by: Medisim Ltd
The study is conducted in order to evaluate the performance of the NIT thrmometer by comparing the predictive measurement to equilibrium measurement and to make a final tuning to the thermometer algorithm.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Petah Tikva, Israel, 49202
- Schneider Children's Medical Center of Israel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
500 patients from both genders, 0-18 years old
Description
Inclusion Criteria:
- Children 0-18 years old, with or without fever that arrive at the unit of emergency medicine in Schneider medical center.
- An informed Consent was signed by the patient or his guardian.
Exclusion Criteria:
- The medical stuff decides that the patient can't participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
With fever
|
Thermometer
|
|
Without fever
|
Thermometer
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (ACTUAL)
March 1, 2010
Study Completion (ACTUAL)
March 1, 2010
Study Registration Dates
First Submitted
September 25, 2008
First Submitted That Met QC Criteria
September 25, 2008
First Posted (ESTIMATE)
September 26, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
April 20, 2012
Last Update Submitted That Met QC Criteria
April 19, 2012
Last Verified
August 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 26-115-25
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Elevated Temperature
-
Eli Lilly and CompanyTerminatedAicardi Goutieres Syndrome | Nakajo-Nishimura Syndrome | Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome | STING-Associated Vasculopathy With Onset in InfancyJapan
-
Diabetica Solutions Inc.National Institutes of Health (NIH)UnknownDiabetes | Elevated Temperature | Neuropathic Limb | Shear Pressure | Increased TemperaturesUnited States
-
Eli Lilly and CompanyApproved for marketingChronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE) | Juvenile Dermatomyositis (JDM) | Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI) | Aicardi-Goutières Syndrome (AGS)United States, United Kingdom
-
Providence CollegeCompletedElevated Blood PressureUnited States
-
Standard Process Inc.Nutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedElevated S-adenosylhomocysteineUnited States
-
Ionis Pharmaceuticals, Inc.CompletedElevated Lipoprotein(a)Netherlands, United Kingdom, Denmark, Germany, Canada
-
Ferrer Internacional S.A.TerminatedElevated LDL CholesterolSpain
-
Texas A&M UniversityCompleted
-
Xention LtdCompleted
-
Clinical Life Sciences Ltd.Completed
Clinical Trials on NIR
-
UConn HealthNational Institute for Biomedical Imaging and Bioengineering (NIBIB)CompletedBreast CancerUnited States
-
Universita di VeronaCompletedClear Cell Renal Carcinoma | Pancreatic Neuroendocrine Tumors | Solid Pseudopapillary Tumors of the PancreasItaly
-
Università Politecnica delle MarcheRecruitingCholecystitis; GallstoneItaly
-
Glyconics LtdActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); University of TexasCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingGynecologic SurgeryUnited States
-
Duke UniversityUnited States Department of DefenseWithdrawn
-
Medinol Ltd.Completed
-
University of FloridaNational Institute on Aging (NIA); University of ArizonaActive, not recruitingCognitive Aging | Alzheimer Disease, Protection AgainstUnited States